Format

Send to

Choose Destination
Annu Rev Pharmacol Toxicol. 2019 Aug 6. doi: 10.1146/annurev-pharmtox-010919-023612. [Epub ahead of print]

The Role of the Microbiome in Drug Response.

Author information

1
MRC London Institute of Medical Sciences, London W12 0NN, United Kingdom; email: f.cabreiro@lms.mrc.ac.uk.

Abstract

The microbiome is known to regulate many aspects of host health and disease and is increasingly being recognized as a key mediator of drug action. However, investigating the complex multidirectional relationships between drugs, the microbiota, and the host is a challenging endeavor, and the biological mechanisms that underpin these interactions are often not well understood. In this review, we outline the current evidence that supports a role for the microbiota as a contributor to both the therapeutic benefits and side effects of drugs, with a particular focus on those used to treat mental disorders, type 2 diabetes, and cancer. We also provide a snapshot of the experimental and computational tools that are currently available for the dissection of drug-microbiota-host interactions. The advancement of knowledge in this area may ultimately pave the way for the development of novel microbiota-based strategies that can be used to improve treatment outcomes. Expected final online publication date for the Annual Review of Pharmacology and Toxicology, Volume 60 is January 6, 2020. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center